4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001464583-26-000002
CHIEF ACCOUNTING OFFICER gave up 3,205 shares (to pay taxes)
- CHIEF ACCOUNTING OFFICER acquired 372 shares (grant or award)
- CHIEF ACCOUNTING OFFICER acquired 7,564 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2026-01-15 | Grant or award | +372 | $24.16 | $8,988 | 27,418 | D: show line 1 in the form |
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2026-04-01 | Option exercise | +7,564 | 34,982 | D: show line 2 in the form | ||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2026-04-01 | Shares withheld for taxes | −3,205 | $48.13 | $154,257 | 31,777 | D: show line 3 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2026-04-01 | Grant or award · Share Option | +14,600 | 14,600 | D: show line 4 in the form | ||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2026-04-01 | Grant or award · Restricted Share Unit | +3,650 | 3,650 | D: show line 5 in the form | ||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2026-04-01 | Grant or award · Performance Share Unit | +7,300 | 7,300 | D: show line 6 in the form | ||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2026-04-01 | Option exercise · Restricted Share Unit | −2,558 | 2,557 | D: show line 7 in the form | ||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2026-04-01 | Option exercise · Restricted Share Unit | −2,362 | 4,725 | D: show line 8 in the form | ||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2026-04-01 | Option exercise · Restricted Share Unit | −2,644 | 7,931 | D: show line 9 in the form |
Loading xslF345X06/form4-04032026_080430.xml…